Akebia Therapeutics Inc
F:AX9
Akebia Therapeutics Inc
F:AX9
Price:
0.8042
EUR
-7.44%
Market Closed
Market Cap:
€168.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Akebia Therapeutics Inc
F:AX9
|
US |
|
D
|
Douglas Dynamics Inc
F:5D4
|
US |
|
Cryoport Inc
F:CKX
|
US |
Intrinsic Value
The intrinsic value for 
Akebia Therapeutics Inc (AX9) under the Base Case is 1.7736 EUR.
Compared with the current market price of 0.8042 EUR, the stock appears
Undervalued by 55% .
Intrinsic value calculated using
DCF
€1.7736
Other reference points
Do our valuations actually work? See backtest results .
AX9
Intrinsic Value
€1.7736
Undervaluation 55%
Monitor AX9
Get notified when the price drops
Free account · No credit card required
Track Buy Zone
20% below Intrinsic Value €1.42
Get notified when the price drops into your buy zone
Or choose another margin of safety
0% below
Intrinsic Value
10% below
Intrinsic Value
30% below
Intrinsic Value
40% below
Intrinsic Value
50% below
Intrinsic Value
Custom
Choose margin of safety
Alternatives to AX9
Fundamental Analysis
Financials
Revenue & Expenses Breakdown
Akebia Therapeutics Inc
Akebia Therapeutics Inc
Efficiency
Earnings Waterfall
Akebia Therapeutics Inc
Akebia Therapeutics Inc
What is the Intrinsic Value of one AX9 stock?
The intrinsic value for Akebia Therapeutics Inc (AX9) under the Base Case is 1.7736 EUR.
Is AX9 stock undervalued or overvalued?
Compared with the current market price of 0.8042 EUR, the stock appears Undervalued by 55% .
